[8] [9] As a precautionary measure, consistent with SmPC guidance for the drug class, retatrutide would be expected to be contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN2) Patients who are pregnant, breastfeeding, or planning pregnancy should not use retatrutide, consistent with guidance applicable to other agents in this class
We can offer you beyond traditional retail pharmacies to compare telehealth programs, manufacturer savings, and compounded GLP-1 treatments
It is true that B12 levels will be depleted by alcohol - the reduction is small with a single drink but probably worse if you go over that
The composition and quantity of compounds in this injectable are shown in the table below
General commentary There are many reasons as to why a preclinical study may fail to translate, particularly, poor experimental design and statistical analysis (for detailed discussions see refs